
Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …

In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …

In its second quarter financial reports, Valeant strove to strike a positive note. It revealed that it had paid down …

Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …

In research that will have many women nodding their brain-boxes, a study has found that analysis of thousands of brains …

It is widely known that Takeda is keen to build its portfolio in oncology and it has made another move …

Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …

As part of Shire’s mega-merger with Baxalta, it suddenly had a massive manufacturing network that spanned 17 sites across seven …

The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …

Zynerba Pharmaceuticals had hoped that its anti-seizure therapy could replicate the kind of success leading competitors had achieved in showing …

Moderna Therapeutics, a clinical stage biotechnology company, has appointed Juan Andres to the position of Senior Vice President of Late …

Bayer has announced that it has received European Commission approval for its treatment of hepatocellular carcinoma, a type of liver …

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

NHS England has announced that it will finally make the HIV-preventing drug, PrEP, available to those at risk with the …